Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)
Clinical trial NCT06975644 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06975644
- Sponsor
- Zhejiang Provincial People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.